
AtriCure ATRC
$ 40.55
0.02%
Quarterly report 2025-Q2
added 07-30-2025
AtriCure Cash Conversion Cycle 2011-2025 | ATRC
Annual Cash Conversion Cycle AtriCure
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 185 | 166 | 142 | 151 | 162 | 132 | 131 | 124 | 108 | 103 | 136 | 87.2 | 62.8 | 81 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 185 | 62.8 | 127 |
Quarterly Cash Conversion Cycle AtriCure
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 176 | 193 | - | 187 | 183 | 183 | - | 175 | 152 | 141 | - | 64.2 | 66.5 | 143 | 41.5 | 149 | 151 | 174 | 36.6 | 180 | 206 | 161 | 41.7 | 134 | 131 | 133 | 43.5 | 130 | 130 | 130 | 45.7 | 131 | 119 | 118 | 46.8 | 109 | 107 | 106 | 49.4 | 106 | 102 | 121 | 54.5 | 138 | 139 | 110 | 56.9 | 88.7 | 88.7 | 74.4 | 49.4 | 68.5 | 59.8 | 69.2 | 51.8 | 85.5 | 78 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 206 | 36.6 | 111 |
Cash Conversion Cycle of other stocks in the Medical instruments industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Baxter International
BAX
|
262 | $ 19.11 | 0.95 % | $ 9.75 B | ||
|
Becton, Dickinson and Company
BDX
|
110 | $ 196.12 | 0.23 % | $ 56.4 B | ||
|
Luminex Corporation
LMNX
|
18.9 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
95.3 | - | -9.52 % | $ 20.6 M | ||
|
Ekso Bionics Holdings
EKSO
|
266 | $ 5.47 | 3.01 % | $ 110 M | ||
|
Antares Pharma, Inc.
ATRS
|
204 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
400 | - | -1.18 % | $ 3.4 B | ||
|
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | ||
|
Harvard Bioscience
HBIO
|
208 | $ 0.73 | 0.64 % | $ 31 M | ||
|
Varian Medical Systems, Inc.
VAR
|
194 | - | -0.02 % | $ 16.3 B | ||
|
iRhythm Technologies
IRTC
|
58.7 | $ 175.8 | -1.49 % | $ 5.48 B | ||
|
ICU Medical
ICUI
|
143 | $ 146.98 | -0.35 % | $ 3.58 B | ||
|
Alcon
ALC
|
134 | $ 80.17 | 0.06 % | $ 40.4 B | ||
|
Repro Med Systems
KRMD
|
149 | $ 6.48 | -0.61 % | $ 295 M | ||
|
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | ||
|
LeMaitre Vascular
LMAT
|
28.7 | $ 84.34 | 0.44 % | $ 1.89 B | ||
|
electroCore
ECOR
|
2.97 | $ 4.86 | 1.25 % | $ 26.8 K | ||
|
AngioDynamics
ANGO
|
124 | $ 13.16 | - | $ 538 M | ||
|
Merit Medical Systems
MMSI
|
171 | $ 87.39 | -0.27 % | $ 5.09 B | ||
|
The Cooper Companies
COO
|
210 | $ 82.57 | -0.37 % | $ 16.4 B | ||
|
Glaukos Corporation
GKOS
|
170 | $ 116.64 | 0.4 % | $ 5.65 B | ||
|
Masimo Corporation
MASI
|
83.7 | $ 133.28 | -0.44 % | $ 7.1 B | ||
|
Haemonetics Corporation
HAE
|
217 | $ 80.01 | -0.44 % | $ 4.03 B | ||
|
InfuSystem Holdings
INFU
|
24.9 | $ 9.11 | 0.77 % | $ 188 M | ||
|
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
208 | $ 577.15 | -0.03 % | $ 205 B | ||
|
OraSure Technologies
OSUR
|
167 | $ 2.43 | 2.53 % | $ 181 M | ||
|
Microbot Medical
MBOT
|
-52.9 | $ 2.18 | - | $ 22.2 M | ||
|
ResMed
RMD
|
167 | $ 244.44 | -0.07 % | $ 35.7 B | ||
|
Milestone Scientific
MLSS
|
545 | $ 0.29 | -0.48 % | $ 23.1 M | ||
|
Nephros
NEPH
|
161 | $ 5.23 | 12.23 % | $ 54.3 M | ||
|
NeuroMetrix
NURO
|
357 | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
79.4 | $ 22.0 | 0.59 % | $ 3.79 B | ||
|
STAAR Surgical Company
STAA
|
26 | $ 23.63 | -1.25 % | $ 1.16 B | ||
|
STERIS plc
STE
|
112 | $ 255.68 | 0.11 % | $ 25.2 B | ||
|
Stereotaxis
STXS
|
212 | $ 2.43 | -0.82 % | $ 196 M | ||
|
Pro-Dex
PDEX
|
193 | $ 40.4 | -2.38 % | $ 133 M | ||
|
Pulse Biosciences
PLSE
|
36.5 | $ 14.86 | 1.92 % | $ 714 M | ||
|
Predictive Oncology
POAI
|
-241 | - | - | $ 32.4 M | ||
|
Utah Medical Products
UTMD
|
280 | $ 56.29 | -1.14 % | $ 204 M | ||
|
Repligen Corporation
RGEN
|
272 | $ 165.66 | -0.42 % | $ 9.23 M | ||
|
DENTSPLY SIRONA
XRAY
|
63.9 | $ 11.22 | 1.26 % | $ 2.28 B | ||
|
BioLife Solutions
BLFS
|
37.9 | $ 25.41 | -0.2 % | $ 1.17 B | ||
|
Retractable Technologies
RVP
|
250 | $ 0.82 | 0.01 % | $ 24.5 M | ||
|
Teleflex Incorporated
TFX
|
183 | $ 122.33 | 0.03 % | $ 5.73 B | ||
|
West Pharmaceutical Services
WST
|
98.9 | $ 276.66 | -0.3 % | $ 20.2 B |